Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rise and shine people. Shout out to Insta. This thing is a beauty waiting to lift off. When this breaks .15 soon look out. And when the company guides their business on Thurs it'll be very nice. I would say this area is equivalent to the base we had 3 years ago around .02-.05. Which means this is going much higher than .30.
Lol not in the sense of a SS. More of a hype thing. You’ll see when this is over $1. This is a gem of a company but you have to admit sometimes things will be very hyped. Two things going for it
Can’t say the name of the platform or the post gets deleted lol
ST is calling this the next GME!! I agree. This baby is running to $1-2+ soon. Everyone wins soon
This is on the exact same path as 2018. The .025-.04 range was bought up heavily, volume slowly built up, then BAM. For the next 2-3 months the short squeeze and buying was on. This setup looks bigger. Take a look at the yearly chart. This is going up big.
I don't buy into this theory of Armen trying to take everything and leave nothing. To believe that you have to believe he has no end goal for the company and is wasting everyone's time involved. That doesn't sound so reasonable to me.
A buyback makes no sense for how big the company is. They've already answered the reasoning for why they won't do it over and over and over again. So you buy back some shares. Then what? That money is better used for the business. Once you become a Microsoft then we can talk about buybacks
Why would you invest in a stock without knowing any of the details for their future? You're new and posting about things that aren't true trying to stir up emotion. Problem is we all did our DD already. On here screaming about an RS yet you say you're invested. Lol yeah I believe you. I always just buy blind as well without knowing anything. You guys crack me up.
How so? Are you saying the common shareholder doesn't know what preferred stock is? Why would they put in the conversion from preferred in the PR? No company has ever done that lol
That wasn’t a guess from me. That was a fact. How can real money flow into this if it’s still stuck on the OTC?
Well that’s definitely not true
How do you intend for the company to fulfill stock price requirements for Nasdaq uplisting without one? The assumption that I keep seeing is that you'll lose equity. How is that possible if the current share price is severely undervalued due to limited access by institutions? The data shows if you uplist correctly the share price effect is positive most of the time. If people are used to the typical trip stock, reverse splitting, and failing miserably on uplist due to no business model, I can't help that. But it shouldn't serve as the benchmark model for what happens when you reserve split. You either believe the company has a profitable business model and long term value or you don't. You can't lose equity if the price appreciates after the split.
The company has made it very clear their plan for their proposal. It's what I posted the other day. They want the day traders out of the stock and they want more long termers. I like it. They've had enough with the OTC scum.
First, certain institutional and other investors have internal policies that prohibit purchases of lower-priced stocks, and a variety of policies and practices of broker-dealers also discourage individual brokers within these firms from dealing in lower-priced stocks.
Second, because the brokers' commissions on lower-priced stocks generally represent a higher percentage of the stock price than commissions on higher-priced stocks, the current market price of our common stock could result in individual stockholders paying transaction costs (commissions, markups or markdowns) that are a higher percentage of the total share value than would be the case if the market price of the shares was higher. This factor is also believed to limit the willingness of some institutions and other investors to purchase shares of our common stock at all. Because we expect a Reverse Stock Split could result in a higher prevailing market price for our common stock, we believe it could help to alleviate some of these negative effects. Also, because of the expected increase in common stock price, we believe a Reverse Stock Split will enable us to carry out our Business Plan, which includes becoming an SEC reporting company and an eventual uplisting to a national stock exchange. The Reverse Stock Split is expected to increase our common stock price to a level that may enable us to meet in part a national stock exchange’s entrance requirements.
Finally, the Board believes the decrease in the number of outstanding shares of our common stock as a consequence of the Reverse Stock Split, coupled with the anticipated increase in the prevailing market price of our common stock, could attract new long-term investors and generate new interest in our common stock, which could potentially promote greater liquidity for our existing stockholders, and could reduce holdings by speculative investors, which could help to reduce volatility in the trading volume and market price of our common stock.
Languishing on the OTC isn't saying much. This is a platform to get companies started to launch off of. This one just happens to be a real legit company that makes money. It really doesn't matter if you bought from .005 to .26. I know some folks have been waiting for those levels again, but the big picture is dollars. Some of the first people on this board thought dollars way before 2018 spikes. They've proved a lot of people wrong including those who said they couldn't uplist. This is going much higher and if it takes time it takes time. They're doing it right that's all that matters.
Speaking of people who have been around for years. No one in the company has sold any shares to date. Which puts holes in just about 100% of all the FUD out there.
The OTC market isn't a fair representation of what the company is valued at. You have a small subset of who's actually interested in investing. Again this is about access to markets to invest. Once they uplist you will see what I mean. The actual value of the company based on profit, share count and forward multiple is much different (much higher) than what the small OTC market is saying it's worth. If you do the math you'll understand
It's about valuation. Why don't you think RXMD will be of equal or greater value post split? Go back in history for OTC and big board splits. Prior to the split you almost always see an enormous appreciation in share price. So if you believe we won't be valued the same or greater after the split, I would sell now. You either believe in the company or you don't. They're not going to value this IPO at a discount. Remember this will be a new listing. They have backers and analysts who need a fair understanding of the value after looking at the share counts and profit. It's all math.
Some of you don't understand what happens when they uplist. There is big money in funds waiting on the sidelines for them to uplist. The volume and money flow will come. They just can't buy now according to their own fund guidelines. There's that side of things no one is thinking about. Any RS is semantics.
It also has to do with the guidelines for Nasdaq. They have to structure the company a particular way. This is all semantics. The only thing that matters is valuation.
I will find the multiple case studies out there. But the research was already posted here years ago about successful uplists from OTC. If done correctly there is an average %% increase pre-split and post-split historically. So the fodder about a split is all mush. This company is doing things by the book. This isn't a fly by night shell merger. This is a legit business uplisting. Armen told me years ago the stock price should be much higher. It will be very soon.
This will easily recover over 3 cents again in the short term. Easy to see
Too much what ifs and speculation in your posts. Progressive Care has always made the right decisions putting shareholders first. This isn't a shell merger with no revenues. You're barking up the wrong tree with this one
Thanks!
Sorry I'm new to this one. What was the IPO price?
Where do you see the next support if any at all?
The reason I don't question it is because of what I said. No bad news or high volume. You need both of those to mean something.
Otherwise the chart looks exactly like RXMD.
You have a run back in early Jan 2018 due to the tax cuts helping small companies.
Then over time you revert back to the mean especially if you have low volume.
This happens to every single company on the OTC. These companies depend on catalysts for stock price movement.
These are not going to behave as an S&P 500 stock does. Building a base then moving up.
You need certain things to take place.
Like I say. Look up RXMD. They bring in millions per month and the stock price has no volume right now.
It doesn't mean it's a bad company.
No they aren't. You think $5,000 is a lot? No one has yet to show me material bearish news on high volume. This is simply a low volume step down.
Show me 50 million and a bearish catalyst and then I'll bite. Until that happens this is simply normal OTC activity.
I don't understand what people are talking about.
.0025s snapped up quickly
Thank you Sharpei. Nice to have you here. Great to have some smart minds discussing this great stock. Merry Christmas/Hanukkah to you and yours as well!
Yup especially since the 20 and 50 are chasing it and will eventually cross it. The bottom was obviously .03. Up big from here easily going into 2020. Huge year ahead. Hold tight people.
I'm ok with that...I hope trips come for all I care. 2020 is going to be a huge year. As long as the business is good I'll still be here.
I see 1M at .0025 via L2
Without a doubt this is the king of the OTC. I've seen it all over the last 7 years. RXMD has no competition on the OTC.
Very close to cash flow positive news. 2020 gonna be huge. We're simply in a waiting pattern until then. Another opportunity I'm taking to buy cheap shares.
Fair enough not sure on that point. I think 2020 is what we need to monitor. I'm gonna watch the first 3 months of the year. And then re-evaluate.
The biggest mistake is trying to connect an OTC stock price to the fundamentals of the company. Now how it works on the OTC.
It's impossible to hold back material events. They release quarterly reports that show everything.
No volume = insignificant move...
Unless there is a bearish catalyst on high volume it means nothing
I've been around the OTC long enough to know they always DIP before they RIP it higher. It's classic textbook moves they make. So if I was a betting man we are going to have another discount on volume, and then they'll rip it back up. Just need to get through another 30 days.
I wouldn't call it manipulation because it happens to every stock. It's just traders. They buy on the bid and sell on the ask. Some of them aren't good at it so they don't break up their asks. Which ends up looking like manipulation.
None of that matters because we're just waiting on material bullish catalysts with volume.
All of this small volume nonsense will go away once we get some good news.
If they want to bring it to .002 and below bring it on.
The money talks and 2020 will be a big year.